Vitamin A and apoptosis in prostate cancer

Endocrine-Related Cancer

Volumn 9, Issue 2, 2002, Pages 87-102

  Zhang, X K ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 [3 (1 ADAMANTYL) 4 HYDROXYPHENYL] 2 NAPHTHOIC ACID; ADAPALENE; ALITRETINOIN; ALPHA INTERFERON; ANDROGEN; ANDROGEN RECEPTOR; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; CALCITRIOL; CASPASE; CELL NUCLEUS RECEPTOR; DNA; ESTROGEN RECEPTOR; FAS ANTIGEN; GLUCOCORTICOID RECEPTOR; OLIGONUCLEOTIDE; PACLITAXEL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; RETINOL; THYROID HORMONE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR; UNINDEXED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CLINICAL TRIAL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; IMMEDIATE EARLY GENE; NONHUMAN; PROSTATE CANCER;

APOPTOSIS; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, RETINOIC ACID; VITAMIN A;

EID: 0036327656     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0090087     Document Type: Article

References (174)

1. Effect of retinoic acid on prostatic development
2. Induction of apoptosis by the novel retinoid AHPN in human T-cell lymphoma cells involves caspase-dependent and independent pathways
3. Inhibition of cell proliferation and induction of apoptosis by the retinoid AHPN in human lung carcinoma cells
4. The Bcl-2 protein family: Arbiters of cell survival
5. Prostate cancer cell cycle regulators: Response to androgen withdrawal and development of androgen independence
6. Retinoic acid-induced spina bifida: Evidence for a pathogenetic mechanism
7. Pathogenesis of retinoid-induced hindbrain malformations in an experimental model
8. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen
9. Lung tumors in mice expressing an antisense RARbeta2 transgene
10. Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor gamma
11. Beyond tamoxifen: The retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma
12. 9-cis retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of fas ligand and requires retinoic acid receptor and retinoid X receptor activation
13. 1,25-Dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1
14. Genes induced during the G0/G1 transition in mouse fibroblasts
15. Apoptosis in prostate carcinogenesis. A growth regulator and a therapeutic target
16. Bcl-2 accelerates multistep prostate carcinogenesis in vivo
17. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
18. The effects of androgen deprivation on the prostate gland: Cell death mediated by vascular regression
19. Expression of retinoic acid receptor-beta sensitizes prostate cancer cells to growth inhibition mediated by combinations of retinoids and a 19-nor hexafluoride vitamin D3 analog
20. Regulation of cell death protease caspase-9 by phosphorylation
21. Identification of a new member of the steroid receptor super-family by cloning and sequence analysis
22. RAR-specific agonist/antagonists which dissociate transactivation and AP1 transrepression inhibit anchorage-independent cell proliferation
23. Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis
24. Inhibition and reversal by beta-retinoic acid of hyperplasia induced in cultured mouse prostate tissue by 3-methylcholanthrene or N-methyl-N′-nitro-N-nitrosoguanidine
25. Signaling for the caspases: Their role in prostate cell apoptosis
26. Adrenocortical function and regulation of the steroid 21-hydroxylase gene in NGFI-B-deficient mice
27. Phase II study of all-trans retinoic acid administered intermittently for hormone refractory prostate cancer
28. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
29. Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer
30. IAP family proteins-suppressors of apoptosis
31. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse
32. Overcoming bcl-2- and p53-mediated resistance in prostate cancer
33. Effect of 13-cis-retinoic acid and alpha-interferon on transforming growth factor beta1 in patients with rising prostate-specific antigen
34. Phase I clinical and pharmacologic study of 13-cis-retinoic acid, interferon alfa, and paclitaxel in patients with prostate cancer and other advanced malignancies
35. Differential expression of genes encoding alpha, beta and gamma retinoic acid receptors and CRABP in the developing limbs of the mouse
36. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
37. The NGFI-B protein, an inducible member of the thyroid/steroid receptor family, is rapidly modified posttranslationally
38. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation
39. Retinoic acid receptor gamma1 (RARgamma1) levels control RARbeta2 expression in SK-N-BE2(c) neuroblastoma cells and regulate a differentiation-apoptosis switch
40. Apoptosis in cancer therapy: Crossing the threshold
41. Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid
42. Unique response pathways are established by allosteric interactions among nuclear hormone receptors
43. High frequency of retinoic acid receptor beta abnormalities in human lung cancer
44. In acute promyelocytic leukemia NB4 cells, the synthetic retinoid CD437 induces contemporaneously apoptosis, a caspase-3-mediated degradation of PML/RARalpha protein and the PML retargeting on PML-nuclear bodies
45. All-trans, 13-cis and 9-cis retinoic acids induce a fully reversible growth inhibition in HNSCC cell lines: Implications for in vivo retinoic acid use
46. Progression to androgen independence is delayed by adjuvant treatment with antisense Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model
47. Androgens decrease and retinoids increase the expression of insulin-like growth factor-binding protein-3 in LNcaP prostatic adenocarcinoma cells
48. Chemoprevention of mammary carcinoma by LGD1069 (Targretin): An RXR-selective ligand
49. The efficacy of 9-cis retinoic acid in experimental models of cancer
50. Effects of retinoic acid (all-trans and 9-cis) on tumor progression in small-cell lung carcinoma
51. A gene inducible by serum growth factors encodes a member of the steroid and thyroid hormone receptor superfamily
52. Primary response genes induced by growth factors and tumor promoters
53. Expression of retinoic acid receptor beta in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acid
54. A retinoic acid receptor-specific element controls the retinoic acid receptor-beta promoter
55. Resistance to apoptosis in prostate cancer cells
56. Retinoid induced apoptosis in leukemia cells through a retinoic acid nuclear receptor-independent pathway
57. Involvement of cyclin-dependent kinase activities in CD437-induced apoptosis
58. Chromosome 10 alterations in prostate adenocarcinoma
59. Retinoic acid receptor beta regulates growth and differentiation in human pancreatic carcinoma cells
60. Nonsteroid nuclear receptors: What are genetic studies telling us about their role in real life?
61. Modulation of retinoid signalling through NGF-induced nuclear export of NGFI-B
62. The development of biologic end points in patients treated with differentiation agents: An experience of retinoids in prostate cancer
63. Evidence that retinoic acid-induced apoptosis in the mouse limb bud core mesenchymal cells is gene-mediated
64. Direct control of the Forkhead transcription factor AFX by protein kinase B
65. Novel therapeutic approach: Organic arsenical melarsoprol alone or with all-trans-retinoic acid markedly inhibits growth of human breast and prostate cancer cells in vitro and in vivo
66. Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: Dissociation from transcriptional activity
67. Oncogenic conversion of a novel orphan nuclear receptor by chromosome translocation
68. The EWS/TEC fusion protein encoded by the t(9;22) chromosomal translocation in human chondrosarcomas is a highly potent transcriptional activator
69. Growth-inhibitory effects of the synthetic retinoid CD437 against ovarian carcinoma models in vitro and in vivo
70. Inhibition of the effects of methylcholanthrene on mouse prostate in organ culture by vitamin A and its analogs
71. Synergistic chemosensitization and inhibition of progression to androgen independence by antisense Bcl-2 oligodeoxynucleotide and paclitaxel in the LNCaP prostate tumor model
72. Differentiation and antiproliferation effects of retinoic acid receptor beta in hepatoma cells
73. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3
74. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
75. Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element
76. Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells
77. Retinoic acid nuclear receptor beta inhibits breast carcinoma anchorage independent growth
78. Molecular determinants of AHPN (CD437)-induced growth arrest and apoptosis in human lung cancer cell lines
79. Synthetic retinoid CD437 induces S-phase arrest and apoptosis in human prostate cancer cells LNCaP and PC-3
80. Differential regulation of primary response gene expression in skeletal muscle cells through multiple signal transduction pathways
81. Orphan receptor COUP-TF is required for induction of retinoic acid receptor beta, growth inhibition, and apoptosis by retinoic acid in cancer cells
82. Unique anti-activator protein-1 activity of retinoic acid receptor beta
83. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis
84. Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells
85. Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77
86. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin
87. Differential expression of nuclear retinoid receptors in normal and malignant prostates
88. A selective retinoid with high activity against an androgen-resistant prostate cancer cell type
89. Chemoprevention of rat prostate carcinogenesis by 9-cis-retinoic acid
90. The RXR heterodimers and orphan receptors
91. The novel retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid can trigger apoptosis through a mitochondrial pathway independent of the nucleus
92. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
93. Antiproliferative activity and apoptosis induced by retinoic acid receptor-gamma selectively binding retinoids in neuroblastoma
94. Developmental analysis of the retinoic acid-inducible RAR-beta 2 promoter in transgenic animals
95. Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation
96. Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene
97. The novel synthetic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) causes apoptosis in acute promyelocytic leukemia cells through rapid activation of caspases
98. Apoptosis in prostatic adenocarcinoma following complete androgen ablation
99. Retinoid-induced apoptosis in normal and neoplastic tissues
100. Modulation of docetaxel-induced apoptosis and cell cycle arrest by all-trans retinoic acid in prostate cancer cells
101. Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells
102. Caspases: The proteases of the apoptotic pathway
103. Rapid induction of apoptosis in human C33A cervical carcinoma cells by the synthetic retinoid 6-[3-(1-adamantyl)hydroxyphenyl]-2-naphthalene carboxylic acid (CD437)
104. Abnormal level of retinoic acid in prostate cancer tissues
105. Changes in tissue transglutaminase activity and expression during retinoic acid-induced growth arrest and apoptosis in primary cultures of human epithelial prostate cells
106. A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1
107. Nuclear receptor/AP-1 interaction
108. Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells
109. Combination of phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth and angiogenesis
110. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype
111. Bcl-2 family proteins
112. Serum vitamin A and subsequent development of prostate cancer in the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study
113. Pathological changes in benign and malignant prostatic tissue following androgen deprivation therapy
114. Retinoid and androgen regulation of cell growth, epidermal growth factor and retinoic acid receptors in normal and carcinoma rat prostate cells
115. Retinoic acid receptors and cellular retinoid binding proteins. II. Their differential pattern of transcription during early morphogenesis in mouse embryos
116. 9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein
117. Effects of various synthetic retinoids on proliferation and immunophenotype of human melanoma cells in vitro
118. Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo
119. Localization of glucocorticoid hormone receptors in mitochondria of human cells
120. Effect of 13-cis-retinoic acid on serum prostate-specific antigen levels in patients with recurrent prostate cancer after radical prostatectomy
121. A natural killer cell granule protein that induces DNA fragmentation and apoptosis
122. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
123. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells
124. Correlations of RAR isoforms and cellular retinoid-binding proteins mRNA levels with retinoid-induced teratogenesis
125. Induction of RAR-beta 2 gene expression in embryos and RAR-beta 2 transactivation by the synthetic retinoid Ro 13-6307 correlates with its high teratogenic potency
126. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
127. Mechanisms and genes of cellular suicide
128. Characterization of an autoregulated response element in the mouse retinoic acid receptor type beta gene
129. Retinoic-acid-induced limb malformations resulting from apical ectodermal ridge cell death
130. Teratogens and craniofacial malformations: Relationships to cell death
131. PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway
132. Induction of apoptosis in human non-small cell lung carcinoma cells by the novel synthetic retinoid CD437
133. Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells
134. Implication of c-Myc in apoptosis induced by the retinoid CD437 in human lung carcinoma cells
135. Implication of p53 in growth arrest and apoptosis induced by the synthetic retinoid CD437 in human lung cancer cells
136. Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells
137. Implication of multiple mechanisms in apoptosis induced by the synthetic retinoid CD437 in human prostate carcinoma cells
138. Retinoic acids regulate apoptosis of T lymphocytes through an interplay between RAR and RXR receptors
139. Radiation-induced apoptosis: Predictive and therapeutic significance in radiotherapy of prostate cancer
140. Effects of N-(4-hydroxyphenyl) retinamide on urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in prostate adenocarcinoma cell lines
141. Fenretinide therapy in prostate cancer: Effects on tissue and serum retinoid concentration
142. Identification of a retinoic acid responsive element in the retinoic acid receptor beta gene
143. Apoptosis in the pathogenesis and treatment of disease
144. Caspases: Enemies within
145. Antisense TR3 orphan receptor can increase prostate cancer cell viability with etoposide treatment
146. Evaluation of biomarker modulation by fenretinide in prostate cancer patients
147. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins
148. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts
149. Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke
150. Modulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR)
151. Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway
152. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression
153. Life, death, and the pursuit of apoptosis
154. Identification of the DNA binding site for NGFI-B by genetic selection in yeast
155. The orphan receptors NGFI-B and steroidogenic factor 1 establish monomer binding as a third paradigm of nuclear receptor-DNA interaction
156. Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas
157. Regulation of the Nur77 orphan steroid receptor in activation-induced apoptosis
158. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids
159. Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization
160. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway
161. Coactivator and corepressor complexes in nuclear receptor function
162. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues
163. Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis
164. Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: Implications for lung cancer development
165. Positive and negative thymic selection in T cell receptor-transgenic mice correlate with Nur77 mRNA expression
166. 9-cis-retinoic acid inhibits activation-driven T-cell apoptosis: Implications for retinoid X receptor involvement in thymocyte development
167. Retinoic acid inhibition of ex vivo human immunodeficiency virus-associated apoptosis of peripheral blood cells
168. Efficient inhibition of activation-induced Fas ligand up-regulation and T cell apoptosis by retinoids requires occupancy of both retinoid X receptors and retinoic acid receptors
169. Tumor-promoting phorbol ester-induced cell death and gene expression in a human prostate adenocarcinoma cell line
170. Hetero- and homodimeric receptors in thyroid hormone and vitamin A action
171. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors
172. Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid
173. A specific defect in the retinoic acid response associated with human lung cancer cell lines
174. Activation of the p38 and JNK/SAPK mitogen-activated protein kinase pathways during apoptosis is mediated by a novel retinoid